March 2024

MIRAMAR, Fla., March 18, 2024 /PRNewswire/ — DifGen Pharmaceuticals LLC (“DifGen”) announced today that it has signed and closed an all-cash transaction through its subsidiary Aveva Drug Delivery Systems Inc. to purchase the operating and manufacturing assets of an FDA-registered m

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: